ArticleHead and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings2025
Application of 3D nnU-Net with Residual Encoder in the 2024 MICCAI Head and Neck Tumor Segmentation Challenge.
Article in Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Overview of the Head and Neck Tumor Segmentation for Magnetic Resonance Guided Applications (HNTS-MRG) 2024 Challenge.Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This article explores the potential of deep learning technologies for the automated identification and delineation of primary tumor volumes (GTVp) and metastatic lymph nodes (GTVn) in radiation therapy planning, specifically using MRI data. Utilizing the high-quality dataset provided by the 2024 MICCAI Head and Neck Tumor Segmentation Challenge, this study employs the 3DnnU-Net model for automatic tumor segmentation. Our experiments revealed that the model performs poorly with high background ratios, which prompted a retraining with selected data of specific background ratios to improve segmentation performance. The results demonstrate that the model performs well on data with low background ratios, but optimization is still needed for high background ratios. Additionally, the model shows better performance in segmenting GTVn compared to GTVp, with DSCagg scores of 0.6381 and 0.8064 for Task 1 and Task 2, respectively, during the final test phase. Future work will focus on optimizing the model and adjusting the network architecture, aiming to enhance the segmentation of GTVp while maintaining the effectiveness of GTVn segmentation to increase accuracy and reliability in clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.